Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 1차 항체

Anti-Human CD14 Recombinant Nanobody (SAA2077) (HY038033)

Anti-Human CD14 Recombinant Nanobody (SAA2077)
Anti-Human CD14 Recombinant Nanobody (SAA2077)
가격(USD):
사양:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HY038033
설명
Anti-Human CD14 Nanobody (SAA2077) [SAA2077] (HY038033) is a alpaca monoclonal antibody detecting CD14 in ELISA. Suitable for Human.
종 반응성Human
응용 분야ELISA
숙주 종Alpaca
클론성Monoclonal
이소타입VHH-8His-Cys-tag
클론 IDSAA2077
타겟 CD14, Monocyte differentiation antigen CD14, Monocyte differentiation antigen CD14, membrane-bound form, Monocyte differentiation antigen CD14, urinary form, My23 antigen, Myeloid cell-specific leucine-rich glycoprotein
내독소 수준 < 10 EU/mg
순도 >95% as determined by SDS-PAGE.
정제 Purified by Nickel column.
등록번호 P08571
형태 Liquid
저장 완충액 0.01M PBS pH 7.4.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

제품 사용 정보
응용 분야 희석
ELISA 1:2000-1:20000
안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
배경

Monocyte differentiation antigen CD14 is a ~40 kDa protein. Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-).

1. Wright, SD. et al. (1990) Science (New York, N.Y.) 249, 1431-3. PMID: 1698311
2. Kelley, SL. et al. (2013) Journal of immunology (Baltimore, Md. : 1950) 190, 1304-11. PMID: 23264655
3. Tsukamoto, H. et al. (2010) International immunology 22, 271-80. PMID: 20133493
4. Murakami, K. et al. (2012) FEBS letters 586, 319-24. PMID: 22265692
5. Haziot, A. et al. (1996) Immunity 4, 407-14. PMID: 8612135
6. Triantafilou, M. et al. (2006) The Journal of biological chemistry 281, 31002-11. PMID: 16880211
7. Estruch, M. et al. (2013) Atherosclerosis 229, 356-62. PMID: 23880187
참고사항 For research use only.
이미지
  • Anti-Human CD14 Recombinant Nanobody (SAA2077)

    SDS-PAGE

    SDS-PAGE for Anti-Human CD14 Nanobody (SAA2077)

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록